ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Jun 23, 2010
Insider Transaction Report
Form 4
MARTINO MICHAEL A
Director
Transactions
- Sale
Common Stock
2010-06-21−1,000→ 11,000 total - Exercise/Conversion
Common Stock
2010-06-22$7.25/sh+943$6,837→ 11,943 total - Exercise/Conversion
stock option (right to buy)
2010-06-21−1,000→ 3,500 totalExercise: $7.25From: 2009-05-12Exp: 2016-05-12→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2010-06-21$7.25/sh+1,000$7,250→ 12,000 total - Sale
Common Stock
2010-06-22−943→ 11,000 total - Exercise/Conversion
Stock option (right to buy)
2010-06-22−943→ 2,557 totalExercise: $7.25From: 2009-05-12Exp: 2016-05-12→ Common Stock (943 underlying)
Footnotes (2)
- [F1]This is the weighted average price. The prices ranged from $14.15 to $14.28. The reporting person undertakes to provide on request a detailed breakout of the pricing
- [F2]This is the weighted average price. The prices ranged from $14.07 to $14.15. The reporting person undertakes to provide on request a detailed breakout of the pricing.